Location out of bounds
Radial
Radial

Newsroom

Resources for journalists

All Press Releases
Versiti Logo

FDA Accepts New Language For “Circular of Information for the Use of Human Blood and Blood Components”

Heartland Blood Center – November 3, 2017

AABB has updated its “Circular of Information for the Use of Human Blood and Blood Components” web page following the FDA’s approval for new language to be inserted in the November 2013 Circular. The updates have been made to provide the approved statement regarding the newly licensed Zika virus (ZIKV) nucleic acid test (NAT). The updated language is intended for use with blood products that have been tested for ZIKV using an FDA-licensed test. In such cases, the FDA requires the insertion of the following language:

  • “A licensed nucleic acid test (NAT) for Zika Virus RNA has been performed and found to be nonreactive.”

This language, developed by the Circular of Information Task Force and accepted by FDA, is similar to that required for other licensed NAT tests.

The insertion of this language is not required for blood products that have been tested for ZIKV under an Investigational New Drug (IND). In such cases, language provided by the IND sponsor remains unchanged.
AABB recommends the use of an adhesive label or an ink stamp to insert the updated language into the Circular. In addition, the version date of November 2013 will not change with this language insertion.

Contact Us

Fay Spano

Director, Public Relations and Corporate Communications
Email (414) 937-6124

Other Press Releases

Versiti Blood Center of Wisconsin launches Every Drop Counts challenge

February 7, 2019

Versiti Blood Center of Wisconsin is bringing together big names in business from around the state to save lives in our community through the Every Drop Counts community challenge.

Read More

Widow honors late husband’s memory with Valentine’s Day blood donation

February 7, 2019

Donate blood at Dennis Buckley Memorial Blood Drive Feb. 9-18 during the Chicago Auto Show at McCormick Place.

Read More

Versiti selected to supply all blood products to Ohio State Wexner Medical Center

January 17, 2019

Beginning July 1, The Ohio State University Wexner Medical Center will work with Milwaukee-based Versiti Inc., for all of its blood and blood products

Read More
ic-arrow-right
x

This website uses cookies to ensure you get the best experience on our website. Learn more